Viridian Therapeutics, Inc. (VRDN): EPS (Diluted)

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest EPS (Diluted) is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-$5.31
Year ended 2023-12-31
2020-12-31: -$31.132021-12-31: -$6.662022-12-31: -$4.052023-12-31: -$5.31-$5.31
2020-12-31 EPS (Diluted) (USD per share) 2023-12-31
Period endedEPS (Diluted)Change YoYSource filing
2023-12-31-$5.31n/m2024-02-27, From 2023-01-01
2022-12-31-$4.05n/m2024-02-27, From 2022-01-01
2021-12-31-$6.66n/m2024-02-27, From 2021-01-01
2020-12-31-$31.13n/a2022-03-11, From 2020-01-01